Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kimball

Showing results (241-250 of 373) with videos related to

Pageof 38
Sort By:
Clinical and Experimental Dermatology|December 2, 2006
Effects of moisturization on epidermal homeostasis and differentiationR W Short, J L Chan, J M Choi, et al.
Cancer|January 15, 2015
Patient navigation based on predictive modeling decreases no-show rates in cancer careSanja Percac-Lima, Patrick R Cronin, David P Ryan, et al.
The British Journal of Dermatology|September 6, 2019
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studiesA B Kimball, K A Papp, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2020
Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impactN M Golbari, J M van der Walt, A Blauvelt, et al.
Journal of the American Academy of Dermatology|August 20, 2019
Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis CouncilBruce Strober, Caitriona Ryan, Peter van de Kerkhof, et al.
Arthritis and Rheumatism|August 16, 2000
Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapyA B Kimball, R M Summers, M Turner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2018
Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trialsR G Langley, A B Kimball, H Nak, et al.
The Journal of Dermatological Treatment|July 25, 2017
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasisSteven R Feldman, Lawrence Green, Alexa B Kimball, et al.
The Journal of Investigative Dermatology|January 17, 2017
Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis SuppurativaAlexander Egeberg, Gregor B E Jemec, Alexa B Kimball, et al.
Journal of the American Academy of Dermatology|March 28, 2019
Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment"Kevin T Savage, Kelsey S Flood, Sabrina Popatia, et al.
Pageof 38

Showing results (241-250 of 373) with videos related to

Sort By:
Pageof 38
Clinical and Experimental Dermatology|December 2, 2006
Effects of moisturization on epidermal homeostasis and differentiationR W Short, J L Chan, J M Choi, et al.
Cancer|January 15, 2015
Patient navigation based on predictive modeling decreases no-show rates in cancer careSanja Percac-Lima, Patrick R Cronin, David P Ryan, et al.
The British Journal of Dermatology|September 6, 2019
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studiesA B Kimball, K A Papp, K Reich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 26, 2020
Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impactN M Golbari, J M van der Walt, A Blauvelt, et al.
Journal of the American Academy of Dermatology|August 20, 2019
Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis CouncilBruce Strober, Caitriona Ryan, Peter van de Kerkhof, et al.
Arthritis and Rheumatism|August 16, 2000
Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapyA B Kimball, R M Summers, M Turner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2018
Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trialsR G Langley, A B Kimball, H Nak, et al.
The Journal of Dermatological Treatment|July 25, 2017
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasisSteven R Feldman, Lawrence Green, Alexa B Kimball, et al.
The Journal of Investigative Dermatology|January 17, 2017
Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis SuppurativaAlexander Egeberg, Gregor B E Jemec, Alexa B Kimball, et al.
Journal of the American Academy of Dermatology|March 28, 2019
Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment"Kevin T Savage, Kelsey S Flood, Sabrina Popatia, et al.
Pageof 38